faster-acting insulin aspart + insulin detemir

A combination of two recombinant insulin analogues, **faster-acting insulin aspart** (a rapid-acting, modified insulin analog) and **insulin detemir** (a long-acting, basal insulin analog). This mixture may be used off-label in diabetes management to reduce the number of daily injections, typically as part of a basal-bolus regimen in people with type 1 diabetes. Faster-acting insulin aspart acts quickly to manage postprandial blood glucose, while insulin detemir maintains basal insulin levels over an extended period. Mixing these two insulins in the same syringe is sometimes practiced, although not manufacturer-recommended, as it may alter the absorption and action profile of the faster-acting insulin aspart, specifically reducing its peak action and prolonging its effect[1][3][4].